MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Juvenile myelomonocytic leukemia, in remission (C93.31)

HealthDay 18 June at 03.49 PM

Trametinib Safe, Effective for Juvenile Myelomonocytic Leukemia

For children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective, according to a study published online June 12 in Cancer Discovery.Noting that patients with relapsed or refractory (advanced) JMML have poor outcomes, Elliot Stieglitz, M.D., from the University of California San Francisc